Wells Fargo & Company Travere Therapeutics, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 39,732 shares of TVTX stock, worth $725,109. This represents 0.0% of its overall portfolio holdings.

Number of Shares

39,732

Previous 42,540 6.6%

Holding current value

$725,109

Previous $349,000 59.03%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$7.89 - $15.21 $22,155 - $42,709	-2,808 Reduced 6.6%	39,732 $555,000
Q2 2024 Aug 13, 2024	BUY	$5.26 - $8.28 $44,357 - $69,825	8,433 Added 24.73%	42,540 $349,000
Q1 2024 May 10, 2024	BUY	$7.18 - $9.82 $11,839 - $16,193	1,649 Added 5.08%	34,107 $262,000
Q4 2023 Feb 09, 2024	SELL	$5.44 - $9.5 $344,743 - $602,034	-63,372 Reduced 66.13%	32,458 $291,000
Q3 2023 Nov 13, 2023	SELL	$7.64 - $17.25 $206,784 - $466,888	-27,066 Reduced 22.02%	95,830 $856,000
Q2 2023 Aug 15, 2023	BUY	$15.3 - $22.61 $803,525 - $1.19 Million	52,518 Added 74.62%	122,896 $1.89 Million
Q1 2023 May 12, 2023	BUY	$17.82 - $22.89 $1.2 Million - $1.54 Million	67,153 Added 2082.26%	70,378 $1.58 Million
Q4 2022 Feb 13, 2023	SELL	$18.47 - $26.14 $39,211 - $55,495	-2,123 Reduced 39.7%	3,225 $67,000
Q3 2022 Nov 14, 2022	BUY	$22.91 - $28.63 $24,811 - $31,006	1,083 Added 25.39%	5,348 $131,000
Q2 2022 Aug 12, 2022	SELL	$20.94 - $30.01 $801,269 - $1.15 Million	-38,265 Reduced 89.97%	4,265 $103,000
Q1 2022 May 16, 2022	SELL	$23.61 - $30.6 $422,500 - $547,587	-17,895 Reduced 29.62%	42,530 $1.1 Million
Q4 2021 Feb 14, 2022	BUY	$24.34 - $31.17 $348,524 - $446,323	14,319 Added 31.06%	60,425 $1.88 Million
Q3 2021 Nov 15, 2021	SELL	$12.98 - $25.03 $2.14 Million - $4.12 Million	-164,520 Reduced 78.11%	46,106 $1.12 Million
Q2 2021 Aug 16, 2021	BUY	$14.11 - $26.4 $839,798 - $1.57 Million	59,518 Added 39.39%	210,626 $3.07 Million
Q1 2021 May 13, 2021	BUY	$23.37 - $31.77 $910,518 - $1.24 Million	38,961 Added 34.74%	151,108 $3.77 Million
Q4 2020 Feb 09, 2021	BUY	$19.17 - $27.87 $2.15 Million - $3.13 Million	112,147 New	112,147 $3.06 Million

Others Institutions Holding TVTX

# of Institutions

193

Shares Held

84.6M

Call Options Held

776K

Put Options Held

900K

View Full List

About Travere Therapeutics, Inc.

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.17B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

More about TVTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Travere Therapeutics, Inc. Transaction History